212 related articles for article (PubMed ID: 20175227)
1. [3H]4-(dimethylamino)-N-(4-(4-(2-methoxyphenyl)piperazin-1-yl) butyl)benzamide: a selective radioligand for dopamine D(3) receptors. II. Quantitative analysis of dopamine D(3) and D(2) receptor density ratio in the caudate-putamen.
Xu J; Hassanzadeh B; Chu W; Tu Z; Jones LA; Luedtke RR; Perlmutter JS; Mintun MA; Mach RH
Synapse; 2010 Jun; 64(6):449-59. PubMed ID: 20175227
[TBL] [Abstract][Full Text] [Related]
2. [(3)H]4-(Dimethylamino)-N-[4-(4-(2-methoxyphenyl)piperazin- 1-yl)butyl]benzamide, a selective radioligand for dopamine D(3) receptors. I. In vitro characterization.
Xu J; Chu W; Tu Z; Jones LA; Luedtke RR; Perlmutter JS; Mintun MA; Mach RH
Synapse; 2009 Sep; 63(9):717-28. PubMed ID: 19425052
[TBL] [Abstract][Full Text] [Related]
3. Pharmacology of [3H]R(+)-7-OH-DPAT binding in the rat caudate-putamen.
Hillefors M; von Euler G
Neurochem Int; 2001 Jan; 38(1):31-42. PubMed ID: 10913686
[TBL] [Abstract][Full Text] [Related]
4. (-)S amisulpride binds with high affinity to cloned dopamine D(3) and D(2) receptors.
Castelli MP; Mocci I; Sanna AM; Gessa GL; Pani L
Eur J Pharmacol; 2001 Dec; 432(2-3):143-7. PubMed ID: 11740949
[TBL] [Abstract][Full Text] [Related]
5. Dopamine (D2/3) receptor agonist positron emission tomography radiotracer [11C]-(+)-PHNO is a D3 receptor preferring agonist in vivo.
Narendran R; Slifstein M; Guillin O; Hwang Y; Hwang DR; Scher E; Reeder S; Rabiner E; Laruelle M
Synapse; 2006 Dec; 60(7):485-95. PubMed ID: 16952157
[TBL] [Abstract][Full Text] [Related]
6. The decrease of dopamine D₂/D₃ receptor densities in the putamen and nucleus caudatus goes parallel with maintained levels of CB₁ cannabinoid receptors in Parkinson's disease: a preliminary autoradiographic study with the selective dopamine D₂/D₃ antagonist [³H]raclopride and the novel CB₁ inverse agonist [¹²⁵I]SD7015.
Farkas S; Nagy K; Jia Z; Harkany T; Palkovits M; Donohou SR; Pike VW; Halldin C; Máthé D; Csiba L; Gulyás B
Brain Res Bull; 2012 Apr; 87(6):504-10. PubMed ID: 22421165
[TBL] [Abstract][Full Text] [Related]
7. II. Localization and characterization of dopamine D4 binding sites in rat and human brain by use of the novel, D4 receptor-selective ligand [3H]NGD 94-1.
Primus RJ; Thurkauf A; Xu J; Yevich E; McInerney S; Shaw K; Tallman JF; Gallagher DW
J Pharmacol Exp Ther; 1997 Aug; 282(2):1020-7. PubMed ID: 9262371
[TBL] [Abstract][Full Text] [Related]
8. Differential regulation of dopamine receptors after chronic typical and atypical antipsychotic drug treatment.
Tarazi FI; Florijn WJ; Creese I
Neuroscience; 1997 Jun; 78(4):985-96. PubMed ID: 9174067
[TBL] [Abstract][Full Text] [Related]
9. Characterization of (125)I-IABN, a novel azabicyclononane benzamide selective for D2-like dopamine receptors.
Luedtke RR; Freeman RA; Boundy VA; Martin MW; Huang Y; Mach RH
Synapse; 2000 Dec; 38(4):438-49. PubMed ID: 11044891
[TBL] [Abstract][Full Text] [Related]
10. Autoradiographic mapping of dopamine-D2/D3 receptor stimulated [35S]GTPgammaS binding in the human brain.
Sóvágó J; Makkai B; Gulyás B; Hall H
Eur J Neurosci; 2005 Jul; 22(1):65-71. PubMed ID: 16029196
[TBL] [Abstract][Full Text] [Related]
11. Characterization of [(3) H]LS-3-134, a novel arylamide phenylpiperazine D3 dopamine receptor selective radioligand.
Rangel-Barajas C; Malik M; Taylor M; Neve KA; Mach RH; Luedtke RR
J Neurochem; 2014 Nov; 131(4):418-31. PubMed ID: 25041389
[TBL] [Abstract][Full Text] [Related]
12. Persistent, specific and dose-dependent effects of toluene exposure on dopamine D2 agonist binding in the rat caudate-putamen.
Hillefors-Berglund M; Liu Y; von Euler G
Toxicology; 1995 Jun; 100(1-3):185-94. PubMed ID: 7624876
[TBL] [Abstract][Full Text] [Related]
13. [3H]raclopride binding to brain tissue from subjects with schizophrenia: methodological aspects.
Dean B; Pavey G; Opeskin K
Neuropharmacology; 1997 Jun; 36(6):779-86. PubMed ID: 9225305
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo comparison of [³H](+)-PHNO and [³H]raclopride binding to rat striatum and lobes 9 and 10 of the cerebellum: a method to distinguish dopamine D₃ from D₂ receptor sites.
Kiss B; Horti F; Bobok A
Synapse; 2011 Jun; 65(6):467-78. PubMed ID: 20936685
[TBL] [Abstract][Full Text] [Related]
15. Autoradiographic visualization of dopamine D-2 receptors in the monkey brain using the selective benzamide drug [3H]raclopride.
Köhler C; Radesäter AC
Neurosci Lett; 1986 May; 66(1):85-90. PubMed ID: 2940480
[TBL] [Abstract][Full Text] [Related]
16. [3H]-quinelorane binds to D2 and D3 dopamine receptors in the rat brain.
Gackenheimer SL; Schaus JM; Gehlert DR
J Pharmacol Exp Ther; 1995 Sep; 274(3):1558-65. PubMed ID: 7562534
[TBL] [Abstract][Full Text] [Related]
17. Novel heterocyclic trans olefin analogues of N-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl}arylcarboxamides as selective probes with high affinity for the dopamine D3 receptor.
Grundt P; Carlson EE; Cao J; Bennett CJ; McElveen E; Taylor M; Luedtke RR; Newman AH
J Med Chem; 2005 Feb; 48(3):839-48. PubMed ID: 15689168
[TBL] [Abstract][Full Text] [Related]
18. Concentration of receptor and ligand revisited in a modified receptor binding protocol for high-affinity radioligands: [3H]Spiperone binding to D2 and D3 dopamine receptors.
Zhen J; Antonio T; Dutta AK; Reith ME
J Neurosci Methods; 2010 Apr; 188(1):32-8. PubMed ID: 20122961
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the in vitro receptor binding properties of N-[3H]methylspiperone and [3H]raclopride to rat and human brain membranes.
Hall H; Wedel I; Halldin C; Kopp J; Farde L
J Neurochem; 1990 Dec; 55(6):2048-57. PubMed ID: 1977888
[TBL] [Abstract][Full Text] [Related]
20. Dopamine D1, D2, D3 receptors, vesicular monoamine transporter type-2 (VMAT2) and dopamine transporter (DAT) densities in aged human brain.
Sun J; Xu J; Cairns NJ; Perlmutter JS; Mach RH
PLoS One; 2012; 7(11):e49483. PubMed ID: 23185343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
